TTNP logo

Titan Pharmaceuticals (TTNP) Cash From Financing

Annual CFF

$10.00 M
+$5.02 M+100.64%

December 31, 2023

Summary

Performance

1-Year Change

+100.64%

3-Year Change

-44.24%

5-Year Change

-5.84%

15-Year Change

+48.61%

TTNP Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.5%
TTNP annual cash flow from financing activities is higher than 57.5% of companies in Healthcare sector

High & Low

All-time High

$83.92 M
TTNP annual cash flow from financing activities is currently -88.08% below its historical high of $83.92 million

3-Year Low

$4.98 M
TTNP annual cash flow from financing activities is currently +100.64% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TTNP previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
TTNP next annual earnings announcement is scheduled for May 15, 2025

OtherTTNPcash flowmetrics:

Annual CFI

$732.00 K
TTNP annual cash flow from investing activities is $732.00 thousand

Annual CFO

-$7.09 M
TTNP annual cash flow from operations is -$7.09 million

Annual FCF

-$7.09 M
TTNP annual free cash flow is -$7.09 million

Annual CAPEX

$2000.00
TTNP annual capital expenditures is $2000.00

Quarterly CFF

$0.00
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

TTNP Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.62%
TTNP quarterly cash flow from financing activities is higher than 45.62% of companies in Healthcare sector

High & Low

All-time High

$41.66 M
TTNP quarterly cash flow from financing activities is currently -100.00% below its historical high of $41.66 million

3-Year Low

$0.00
TTNP quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TTNP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
TTNP next earnings announcement is scheduled for May 15, 2025

OtherTTNPcash flowmetrics:

Quarterly CFI

$0.00
TTNP quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$693.00 K
TTNP quarterly cash flow from operations is -$693.00 thousand

Quarterly FCF

-$693.00 K
TTNP quarterly free cash flow is -$693.00 thousand

Quarterly CAPEX

-
TTNP quarterly capital expenditures value is unknown

TTM CFF

$406.00 K
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-95.94%

3-Year Change

-91.85%

5-Year Change

-97.83%

TTNP TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.82%
TTNP TTM cash flow from financing activities is higher than 30.82% of companies in Healthcare sector

High & Low

All-time High

$83.92 M
TTNP TTM cash flow from financing activities is currently -99.52% below its historical high of $83.92 million

3-Year Low

$406.00 K
TTNP TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TTNP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
TTNP next earnings announcement is scheduled for May 15, 2025

OtherTTNPcash flowmetrics:

TTM CFI

$504.00 K
TTNP TTM cash flow from investing activities is $504.00 thousand

TTM CFO

-$5.62 M
TTNP TTM cash flow from operations is -$5.62 million

TTM FCF

-$5.62 M
TTNP TTM free cash flow is -$5.62 million

TTM CAPEX

-
TTNP TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TTNP Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.6%-100.0%-95.9%
3 y3 years-44.2%-100.0%-91.8%
5 y5 years-5.8%-100.0%-97.8%

TTNP Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.6%-100.0%at low-95.9%at low
5 y5-year-44.2%+100.6%-100.0%at low-98.0%at low
alltimeall time-88.1%>+9999.0%-100.0%+100.0%-99.5%+131.2%

Titan Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
$406.00 K(-95.9%)
Dec 2023
$10.00 M(+100.6%)
$406.00 K(-95.8%)
$10.00 M(+4.2%)
Sep 2023
-
$9.59 M(>+9900.0%)
$9.59 M(+92.5%)
Dec 2022
$4.98 M(-43.6%)
$0.00(0.0%)
$4.98 M(0.0%)
Sep 2022
-
$0.00(-100.0%)
$4.98 M(0.0%)
Jun 2022
-
$3000.00(-99.9%)
$4.98 M(+0.1%)
Mar 2022
-
$4.98 M(>+9900.0%)
$4.98 M(-43.7%)
Dec 2021
$8.84 M(-50.7%)
$0.00(0.0%)
$8.84 M(-40.1%)
Sep 2021
-
$0.00(0.0%)
$14.75 M(-14.3%)
Jun 2021
-
$0.00(-100.0%)
$17.22 M(-8.0%)
Mar 2021
-
$8.84 M(+49.6%)
$18.72 M(+4.4%)
Dec 2020
$17.93 M(+59.1%)
$5.91 M(+139.7%)
$17.93 M(-10.8%)
Sep 2020
-
$2.47 M(+64.4%)
$20.10 M(+2.3%)
Jun 2020
-
$1.50 M(-81.4%)
$19.65 M(+5.0%)
Mar 2020
-
$8.06 M(-0.2%)
$18.72 M(+66.1%)
Dec 2019
$11.27 M(+6.1%)
$8.08 M(+300.8%)
$11.27 M(+46.1%)
Sep 2019
-
$2.02 M(+252.9%)
$7.71 M(-47.9%)
Jun 2019
-
$571.00 K(-5.6%)
$14.80 M(+4.0%)
Mar 2019
-
$605.00 K(-86.6%)
$14.22 M(+33.9%)
Dec 2018
$10.62 M(+57.8%)
$4.52 M(-50.3%)
$10.62 M(+82.6%)
Sep 2018
-
$9.10 M(>+9900.0%)
$5.82 M(+56.0%)
Jun 2018
-
$0.00(-100.0%)
$3.73 M(0.0%)
Mar 2018
-
-$3.00 M(+960.1%)
$3.73 M(-44.6%)
Dec 2017
$6.73 M(>+9900.0%)
-$283.00 K(-104.0%)
$6.73 M(-4.0%)
Sep 2017
-
$7.01 M(>+9900.0%)
$7.01 M(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
$27.00 K(0.0%)
Dec 2016
$27.00 K(-292.9%)
$0.00(0.0%)
$27.00 K(0.0%)
Sep 2016
-
$0.00(-100.0%)
$27.00 K(0.0%)
Jun 2016
-
$27.00 K(>+9900.0%)
$27.00 K(-292.9%)
Dec 2015
-$14.00 K(-100.1%)
$0.00(0.0%)
-$14.00 K(-100.1%)
Sep 2015
-
$0.00(0.0%)
$9.58 M(0.0%)
Jun 2015
-
$0.00(-100.0%)
$9.58 M(+0.4%)
Mar 2015
-
-$14.00 K(-100.1%)
$9.54 M(-0.1%)
Dec 2014
$9.55 M(+150.6%)
$9.59 M(>+9900.0%)
$9.55 M(+95.5%)
Sep 2014
-
$0.00(-100.0%)
$4.89 M(0.0%)
Jun 2014
-
-$37.00 K(<-9900.0%)
$4.89 M(+101.6%)
Mar 2014
-
$0.00(-100.0%)
$2.42 M(-36.4%)
Dec 2013
$3.81 M(-68.3%)
$4.92 M(>+9900.0%)
$3.81 M(+48.7%)
Sep 2013
-
$0.00(-100.0%)
$2.56 M(-57.5%)
Jun 2013
-
-$2.50 M(-280.1%)
$6.03 M(-55.2%)
Mar 2013
-
$1.39 M(-62.2%)
$13.45 M(+11.9%)
Dec 2012
$12.02 M(-29.0%)
$3.68 M(+6.0%)
$12.02 M(-9.9%)
Sep 2012
-
$3.47 M(-29.5%)
$13.34 M(+35.1%)
Jun 2012
-
$4.92 M(<-9900.0%)
$9.88 M(-42.5%)
Mar 2012
-
-$44.00 K(-100.9%)
$17.16 M(+1.3%)
Dec 2011
$16.94 M(+271.0%)
$5.00 M(>+9900.0%)
$16.94 M(+45.1%)
Sep 2011
-
$0.00(-100.0%)
$11.67 M(-29.3%)
Jun 2011
-
$12.21 M(-4588.2%)
$16.50 M(+284.4%)
Mar 2011
-
-$272.00 K(+3.4%)
$4.29 M(-6.0%)
Dec 2010
$4.57 M(+13.2%)
-$263.00 K(-105.4%)
$4.57 M(-45.6%)
Sep 2010
-
$4.83 M(>+9900.0%)
$8.38 M(+107.9%)
Jun 2010
-
$0.00(0.0%)
$4.03 M(0.0%)
Mar 2010
-
$0.00(-100.0%)
$4.03 M(0.0%)
Dec 2009
$4.03 M
$3.56 M(+647.3%)
$4.03 M(+747.3%)
DateAnnualQuarterlyTTM
Sep 2009
-
$476.00 K(>+9900.0%)
$476.00 K(>+9900.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(-100.0%)
Sep 2008
-
$0.00(0.0%)
$20.85 M(-0.1%)
Jun 2008
-
$0.00(-100.0%)
$20.88 M(-32.8%)
Mar 2008
-
-$26.00 K(-100.1%)
$31.09 M(-0.4%)
Dec 2007
$31.21 M(+215.6%)
$20.87 M(>+9900.0%)
$31.21 M(+198.0%)
Sep 2007
-
$31.00 K(-99.7%)
$10.47 M(-0.1%)
Jun 2007
-
$10.21 M(>+9900.0%)
$10.49 M(+3857.0%)
Mar 2007
-
$96.00 K(-30.4%)
$265.00 K(-97.3%)
Dec 2006
$9.89 M(+143.2%)
$138.00 K(+206.7%)
$9.89 M(-27.9%)
Sep 2006
-
$45.00 K(-421.4%)
$13.72 M(+0.2%)
Jun 2006
-
-$14.00 K(-100.1%)
$13.69 M(-0.5%)
Mar 2006
-
$9.72 M(+144.9%)
$13.76 M(+238.4%)
Dec 2005
$4.07 M(-72.1%)
$3.97 M(>+9900.0%)
$4.07 M(+3736.8%)
Sep 2005
-
$16.00 K(-72.4%)
$106.00 K(-27.4%)
Jun 2005
-
$58.00 K(+141.7%)
$146.00 K(+31.5%)
Mar 2005
-
$24.00 K(+200.0%)
$111.00 K(-99.2%)
Dec 2004
$14.57 M(>+9900.0%)
$8000.00(-85.7%)
$14.57 M(-0.4%)
Sep 2004
-
$56.00 K(+143.5%)
$14.62 M(+0.1%)
Jun 2004
-
$23.00 K(-99.8%)
$14.61 M(+0.1%)
Mar 2004
-
$14.48 M(>+9900.0%)
$14.59 M(>+9900.0%)
Dec 2003
$113.00 K(-2925.0%)
$66.00 K(+78.4%)
$113.00 K(+169.0%)
Sep 2003
-
$37.00 K(+270.0%)
$42.00 K(+950.0%)
Jun 2003
-
$10.00 K(>+9900.0%)
$4000.00(-180.0%)
Mar 2003
-
$0.00(-100.0%)
-$5000.00(+25.0%)
Dec 2002
-$4000.00(-100.4%)
-$5000.00(+400.0%)
-$4000.00(-105.6%)
Sep 2002
-
-$1000.00(-200.0%)
$72.00 K(-2.7%)
Jun 2002
-
$1000.00(0.0%)
$74.00 K(-75.3%)
Mar 2002
-
$1000.00(-98.6%)
$300.00 K(-67.4%)
Dec 2001
$921.00 K(-98.9%)
$71.00 K(+7000.0%)
$921.00 K(-97.8%)
Sep 2001
-
$1000.00(-99.6%)
$41.92 M(-1.2%)
Jun 2001
-
$227.00 K(-63.5%)
$42.44 M(-1.0%)
Mar 2001
-
$622.00 K(-98.5%)
$42.87 M(-48.9%)
Dec 2000
$83.92 M(+83.2%)
$41.07 M(+7737.8%)
$83.92 M(+1.5%)
Sep 2000
-
$524.00 K(-20.1%)
$82.64 M(+0.4%)
Jun 2000
-
$656.00 K(-98.4%)
$82.32 M(+0.8%)
Mar 2000
-
$41.66 M(+4.7%)
$81.67 M(+78.3%)
Dec 1999
$45.80 M(>+9900.0%)
$39.80 M(>+9900.0%)
$45.80 M(+663.3%)
Sep 1999
-
$200.00 K(>+9900.0%)
$6.00 M(+3.4%)
Jun 1999
-
$0.00(-100.0%)
$5.80 M(-1.7%)
Mar 1999
-
$5.80 M(>+9900.0%)
$5.90 M(+2850.0%)
Dec 1998
$200.00 K(-94.6%)
$0.00(0.0%)
$200.00 K(-96.2%)
Sep 1998
-
$0.00(-100.0%)
$5.30 M(0.0%)
Jun 1998
-
$100.00 K(0.0%)
$5.30 M(+32.5%)
Mar 1998
-
$100.00 K(-98.0%)
$4.00 M(+8.1%)
Dec 1997
$3.70 M(-84.9%)
$5.10 M(>+9900.0%)
$3.70 M(-384.6%)
Sep 1997
-
$0.00(-100.0%)
-$1.30 M(-110.6%)
Jun 1997
-
-$1.20 M(+500.0%)
$12.30 M(-9.6%)
Mar 1997
-
-$200.00 K(-300.0%)
$13.60 M(-44.5%)
Dec 1996
$24.50 M(+195.2%)
$100.00 K(-99.3%)
$24.50 M(+0.4%)
Sep 1996
-
$13.60 M(>+9900.0%)
$24.40 M(+125.9%)
Jun 1996
-
$100.00 K(-99.1%)
$10.80 M(+0.9%)
Mar 1996
-
$10.70 M
$10.70 M
Dec 1995
$8.30 M
-
-

FAQ

  • What is Titan Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals annual CFF year-on-year change?
  • What is Titan Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly CFF year-on-year change?
  • What is Titan Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals TTM CFF year-on-year change?

What is Titan Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of TTNP is $10.00 M

What is the all time high annual CFF for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual cash flow from financing activities is $83.92 M

What is Titan Pharmaceuticals annual CFF year-on-year change?

Over the past year, TTNP annual cash flow from financing activities has changed by +$5.02 M (+100.64%)

What is Titan Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of TTNP is $0.00

What is the all time high quarterly CFF for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly cash flow from financing activities is $41.66 M

What is Titan Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, TTNP quarterly cash flow from financing activities has changed by -$406.00 K (-100.00%)

What is Titan Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of TTNP is $406.00 K

What is the all time high TTM CFF for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high TTM cash flow from financing activities is $83.92 M

What is Titan Pharmaceuticals TTM CFF year-on-year change?

Over the past year, TTNP TTM cash flow from financing activities has changed by -$9.59 M (-95.94%)